Physician profile
Thomas Zaciewski
NPI 1467618447
$6,090.72
in general payments reported to CMS, 2019-2025
37 companies · $2,443 in 2025
The $2,443 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $259 · 2021: $385 · 2022: $1,534 · 2023: $549 · 2024: $476 · 2025: $2,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,855 · Travel and Lodging: $1,612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,854.70 |
| Travel and Lodging | $1,612.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,434.70 | 2022-2025 | Altaviva, Interstim |
| Astellas Pharma US INC | $559.85 | 2019-2023 | Myrbetriq |
| Endo Pharmaceuticals INC. | $258.77 | 2019-2023 | Edex, Xiaflex, Aveed |
| Olympus America INC. | $166.06 | 2023-2025 | Itind System, Soltive |
| Calyxo, INC. | $151.67 | 2025 | Cvac Aspiration System |
| Myovant Sciences INC. | $145.57 | 2021-2022 | |
| Boston Scientific Corporation | $137.43 | 2019-2024 | Lithovue, Rezum Generator |
| Sumitomo Pharma America, INC. | $113.61 | 2023-2025 | Orgovyx, Gemtesa |
| Tolmar Pharmaceuticals, INC. | $113.61 | 2019-2022 | |
| Axonics, INC. | $94.09 | 2022-2024 | Axonics, Bulkamid |
| Procept Biorobotics Corporation | $86.41 | 2021-2024 | Aquabeam Robotic System, Aquabeam System |
| Merck Sharp & Dohme LLC | $74.49 | 2021-2024 | Keytruda, Lynparza, Welireg |
| Abbvie INC. | $67.17 | 2022-2025 | |
| Dornier Medtech America, INC | $61.56 | 2024 | Dornier Medtech |
| Laborie Medical Technologies Corp. | $55.35 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $49.57 | 2025 | |
| Tolmar, INC. | $49.33 | 2023 | |
| Janssen Biotech, INC. | $46.81 | 2019-2023 | Erleada |
| Teleflex LLC | $44.50 | 2021 | |
| Urovant Sciences INC | $43.41 | 2021-2022 | |
| Endo USA, INC. | $38.89 | 2025 | Xiaflex, Aveed |
| Ambu INC. | $36.08 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $27.36 | 2021-2022 | |
| Coloplast Corp | $27.26 | 2022 | |
| Telix Pharmaceuticals | $24.80 | 2023 | Illuccix |
| Blue Earth Diagnostics | $19.36 | 2024 | |
| Ferring Pharmaceuticals INC. | $19.21 | 2019 | |
| Immunitybio, INC. | $17.92 | 2025 | |
| Progenics Pharmaceuticals, INC. | $17.49 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $16.62 | 2023 | Lynparza |
| Sagent Pharmaceuticals | $15.28 | 2025 | Glydo |
| Verity Pharmaceuticals INC. | $14.85 | 2024 | Trelstar |
| Cook Medical LLC | $14.70 | 2021 | |
| Dendreon Pharmaceuticals LLC | $13.08 | 2019 | |
| Medtronic USA, INC. | $12.66 | 2019 | |
| Davol INC. | $11.56 | 2020 | |
| Richard Wolf Medical Instruments Corp. | $9.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Zaciewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.